2nd Quarter - Amendment

PURDUE PHARMA, LP for PURDUE PHARMA LP

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Aug 11, 2016 $250,000 Replaced
2nd Quarter - Amendment (this page) Aug 11, 2016 $250,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation

LobbyistCovered position, as disclosed
BURT E ROSEN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 2839 (114th)

Copyright/Patent/Trademark CPT

Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation

LobbyistCovered position, as disclosed
BURT E ROSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 2839 (114th)

Health Issues HCR

Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation

LobbyistCovered position, as disclosed
BURT E ROSEN —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2839 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.